tuberculosis In 2017, a Work Group was assembled to conduct a systematic review of 3HP regimen studies published between January 2006 to June 2017, specifically looking at outcomes in children, ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving 3HP reported mostly mild symptoms that occurred early and resolved without stopping treatment ...

ATLANTA — The Centers for Disease Control and Prevention on Thursday released new recommendations to treat latent tuberculosis infection. The new recommendations, published in CDC’s Morbidity and ...

The CDC and National Tuberculosis Controllers Association, or NTCA, has published updated recommendations for latent tuberculosis, or LTBI, in the MMWR for the first time since 2000. To develop the ...

Directly observed therapy — where a health professional watches someone take a medication — has been the standard of care for tuberculosis treatment in the United States since 2016. Now DOT, as it’s ...

Effective treatment of latent tuberculosis infection is key to TB control efforts and approaching the goal of TB elimination, the authors reported. This article is written live from ID Week 2017 ...

A lab crucial to diagnosing cases of drug-resistant tuberculosis at the Centers for Disease Control and Prevention has reopened, according to the CDC. The Atlanta lab was closed several weeks ago ...

A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with ...